Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Operating Leases (2019 - 2025)

Historic Operating Leases for Lemaitre Vascular (LMAT) over the last 10 years, with Q3 2025 value amounting to $17.2 million.

  • Lemaitre Vascular's Operating Leases fell 610.06% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year decrease of 610.06%. This contributed to the annual value of $15.2 million for FY2024, which is 837.34% down from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's Operating Leases is $17.2 million, which was down 610.06% from $14.9 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Operating Leases registered a high of $18.9 million during Q1 2024, and its lowest value of $14.1 million during Q4 2021.
  • In the last 5 years, Lemaitre Vascular's Operating Leases had a median value of $16.6 million in 2023 and averaged $16.4 million.
  • In the last 5 years, Lemaitre Vascular's Operating Leases soared by 1440.17% in 2024 and then crashed by 2192.56% in 2025.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Operating Leases stood at $14.1 million in 2021, then grew by 4.57% to $14.7 million in 2022, then rose by 13.01% to $16.6 million in 2023, then decreased by 8.37% to $15.2 million in 2024, then increased by 12.97% to $17.2 million in 2025.
  • Its last three reported values are $17.2 million in Q3 2025, $14.9 million for Q2 2025, and $14.7 million during Q1 2025.